Stock INTI INHIBITOR THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Inhibitor Therapeutics, Inc.

Equities

INTI

US45720M1053

Market Closed - OTC Markets
Other stock markets
 15:39:25 20/06/2024 BST 		5-day change 1st Jan Change
0.079 USD -0.05% Intraday chart for Inhibitor Therapeutics, Inc. 0.00% -14.13%
05-13 Inhibitor Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
03-29 Inhibitor Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Other languages

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Inhibitor Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Inhibitor Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Inhibitor Therapeutics, Inc. Announces the Use of Itraconazole to Treat Basal Cell Carcinoma Nevus Syndrome
Introducing Inhibitor Therapeutics, Inc. Announces Scientific Advisory Board
Inhibitor Therapeutics, Inc. Enters into an Exclusive, Worldwide Licensing Agreement with Johns Hopkins University
Inhibitor Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Inhibitor Therapeutics, Inc. Appoints Michelle Yanez as an Independent Director and a Member of the Audit Committee
Inhibitor Therapeutics, Inc. Appoints Ronald E. Osman as Non-Independent Director on the Board
Inhibitor Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Inhibitor Therapeutics, Inc. Announces Board Changes
Inhibitor Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Inhibitor Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Inhibitor Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Inhibitor Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Inhibitor Therapeutics, Inc. Announces Retirement of Debra Peattie from the Board of Directors
Inhibitor Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
Inhibitor Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
Inhibitor Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt
Inhibitor Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
Inhibitor Therapeutics, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. INTI Stock
  4. News Inhibitor Therapeutics, Inc.
  5. Other languages